Lebrikizumab is an interleukin-13 antagonist approved as Ebglyss for the treatment of adults and pediatric patients with moderate to severe atopic dermatitis.

The Galleri blood test did not significantly reduce late stage cancer diagnoses among healthy adults in a large scale study.

The data suggest significant challenges in maintaining long-term disease control with advanced systemic therapies for atopic dermatitis.

Exposure to low-credibility health content was limited overall but increased with age and factors other than health-related browsing.

Ralph Abraham, the deputy secretary general of the CDC, stepped down effective immediately on Monday, February 23.

Medical influencers and social media, having changed the ways in which physicians communicate, now carry certain ethical ...

Increasing use of Mohs micrographic surgery was observed from 2011 to 2022, with no significant differences seen in patients of varying skin colors.

High meat intake was linked to increased odds of reporting high psoriasis severity, were plant-based proteins were linked to low severity.